Kezar Life Sciences Inc

NASDAQ:KZR 4:00:00 PM EDT

1.12

-0.02 (-1.75%)

: $1.08 -0.04 (-3.57%)

Market Cap (Intraday)	81.42M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.5 Million
Adjusted EPS	-$0.36

See more estimates

10-Day MA	$1.19
50-Day MA	$1.67
200-Day MA	$3.70

See more pivots

Kezar Life Sciences Inc Stock, NASDAQ:KZR

4000 Shoreline Court, Suite 300, South San Francisco, California 94080

United States of America

Phone: +1.650.822.5600

Number of Employees: 84

http://www.kezarlifesciences.com

Description

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.